UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemokines mediate ethanol‐induced exacerbations of murine cockroach allergen asthma

Clinical and experimental immunology, 2013-05, Vol.172 (2), p.203-216

2013

Volltextzugriff (PDF)

Otelixizumab – dose regimen optimization of a chimeric/humanized aglycosylated anti-CD3 monoclonal antibody (MAb) in adult subjects with type 1 diabetes mellitus (T1DM)

Canadian journal of diabetes, 2009, Vol.33 (3), p.205-205

2009

Volltextzugriff (PDF)

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers

Pharmaceutical research, 2006, Vol.23 (1), p.95-103

2006

Volltextzugriff (PDF)

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity

Clinical cancer research, 1996-04, Vol.2 (4), p.669-677

1996

Volltextzugriff (PDF)

Immunoregulatory properties of TRX585, a novel monoclonal antibody specific for immunoglobulin-like transcript 5

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13107-e13107

2010

Volltextzugriff (PDF)

Levalbuterol hydrochloride

Expert opinion on investigational drugs, 1998-12, Vol.7 (12), p.2027-2041

1998

Volltextzugriff (PDF)

Effect of the antimouse GITR mab plus chemotherapy on survival and tumor immunity

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13147-e13147

2010

Volltextzugriff (PDF)

Development of TRX518, an aglycosyl humanized monoclonal antibody (Mab) agonist of huGITR

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13028-e13028

2010

Volltextzugriff (PDF)

Otelixizumab Induces Expansion of Human CD4+FoxP3+ Cells in vitro

Clinical immunology (Orlando, Fla.), 2008-01, Vol.127, p.S100-S100

2008

Volltextzugriff (PDF)

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen

Clinical cancer research, 1995-11, Vol.1 (11), p.1285-1294

1995

Volltextzugriff (PDF)

Malignancy‐related pericardial effusion. 127 cases from the roswell park cancer institute

Cancer, 1995-10, Vol.76 (8), p.1377-1387

1995

Volltextzugriff (PDF)

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF)

Leukemia, 1993-10, Vol.7 (10), p.1680

1993

Volltextzugriff (PDF)

Antiproliferative monoclonal antibodies: detection and initial characterization

The Journal of immunology (1950), 1985-09, Vol.135 (3), p.1987-1997

1985

Volltextzugriff (PDF)

Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study

The American journal of emergency medicine, 2004, Vol.22 (1), p.29-36

2004

Volltextzugriff (PDF)

Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus

Journal of Clinical Microbiology, 1992-02, Vol.30 (2), p.351-358

1992

Volltextzugriff (PDF)

Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T-Cell Lymphoma

Annals of the New York Academy of Sciences, 1993-08, Vol.690 (1), p.376-377

1993

Volltextzugriff (PDF)

Carboplatin for small cell lung cancer : progress toward greater efficacy and reduced toxicity

Seminars in oncology, 1994-06, Vol.21 (3), p.1-8

1994

Volltextzugriff (PDF)

Expression of CD3 and T Cell Receptor (TCR) on a Minor Population of Human CD14 Positive Cells

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S52-S53

2007

Volltextzugriff (PDF)

Phase IA/IB Evaluation of Mammalian Cell-derived Glycosylated Recombinant Human Interleukin (SIGOSIX) before and after Cytotoxic Chemotherapy

Annals of the New York Academy of Sciences, 1995-07, Vol.762 (1), p.359-360

1995

Volltextzugriff (PDF)

Pericarditis induced by high-dose cytarabine therapy

Archives of internal medicine (1960), 1984-01, Vol.144 (9), p.1868-1869

Vaickus, L.

1984

Volltextzugriff (PDF)

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease

Journal of immunotherapy, 1991-04, Vol.10 (2), p.141-146

1991

Volltextzugriff (PDF)

Interleukin-2 with Ex Vivo Activated Killer Cells: Therapy of Advanced Non-Small-Cell Lung Cancer

Journal of immunotherapy (1997), 1991-10, Vol.10 (5), p.383-387

1991

Volltextzugriff (PDF)

Consecutive doses of levalbuterol and racemic albuterol result in comparable safety and efficacy: A pharmacokinetic and pharmacodynamic study in mild-moderate asthmatics

Annals of emergency medicine, 1999-10, Vol.34 (4), p.S55-S55

1999

Volltextzugriff (PDF)

606 Norastemizole (NORA) acts earlier and is more effective for allergic rhinitis symptoms than loratadine (LAT) and placebo (PBO) in an allergen challenge system

Journal of allergy and clinical immunology, 2000, Vol.105 (1), p.S202-S202

2000

Volltextzugriff (PDF)

PEN9: PHARMACODYNAMIC-PHARMACOECONOMIC (PD-PE) MODEL OF ASTHMA ANTI-INFLAMMATORY THERAPIES

Value in health, 1999-09, Vol.2 (5), p.396-397

1999

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(35)
Biological And Medical Sciences
(24)
Medical Sciences
(19)
Female
(15)
Male
(14)
Oncology
(13)
Adult
(11)
Animals
(11)
Pharmacology. Drug Treatments
(11)
Mice
(10)
Middle Aged
(10)
Immunology
(9)
Antineoplastic Agents
(7)
Aged
(6)
Hematology
(6)
Immunotherapy
(6)
Antibodies, Monoclonal - Immunology
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Chemokines mediate ethanol‐induced exacerbations of murine cockroach allergen asthma

Otelixizumab – dose regimen optimization of a chimeric/humanized aglycosylated anti-CD3 monoclonal antibody (MAb) in adult subjects with type 1 diabetes mellitus (T1DM)

Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity

Immunoregulatory properties of TRX585, a novel monoclonal antibody specific for immunoglobulin-like transcript 5

Levalbuterol hydrochloride

Effect of the antimouse GITR mab plus chemotherapy on survival and tumor immunity

Development of TRX518, an aglycosyl humanized monoclonal antibody (Mab) agonist of huGITR

Otelixizumab Induces Expansion of Human CD4+FoxP3+ Cells in vitro

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen

Malignancy‐related pericardial effusion. 127 cases from the roswell park cancer institute

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF)

Antiproliferative monoclonal antibodies: detection and initial characterization

Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study

Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus

Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T-Cell Lymphoma

Carboplatin for small cell lung cancer : progress toward greater efficacy and reduced toxicity

Expression of CD3 and T Cell Receptor (TCR) on a Minor Population of Human CD14 Positive Cells

Phase IA/IB Evaluation of Mammalian Cell-derived Glycosylated Recombinant Human Interleukin (SIGOSIX) before and after Cytotoxic Chemotherapy

Pericarditis induced by high-dose cytarabine therapy

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease

Interleukin-2 with Ex Vivo Activated Killer Cells: Therapy of Advanced Non-Small-Cell Lung Cancer

Consecutive doses of levalbuterol and racemic albuterol result in comparable safety and efficacy: A pharmacokinetic and pharmacodynamic study in mild-moderate asthmatics

606 Norastemizole (NORA) acts earlier and is more effective for allergic rhinitis symptoms than loratadine (LAT) and placebo (PBO) in an allergen challenge system

PEN9: PHARMACODYNAMIC-PHARMACOECONOMIC (PD-PE) MODEL OF ASTHMA ANTI-INFLAMMATORY THERAPIES

Suchergebnisse filtern